News articles

News article list

• Thousands more breast cancer patients to benefit from new NHS treatment

  NICE approves ribociclib combination therapy to help prevent cancer returning in early-stage disease.

• Four AI technologies conditionally recommended to help detect undiagnosed fragility fractures

  The technologies could help healthcare professionals spot hidden spinal fractures in patients undergoing routine CT scans.

• New cystic fibrosis drug fast-tracked for NHS use

  Some people with cystic fibrosis are set to benefit from a new once-daily triple therapy treatment, following NICE's recommendation of Alyftrek in final draft guidance published today.

• NICE provisionally recommends leadless implantable pacemaker in draft guidance

  A procedure for people with slow heart rhythms could be used more widely after it was recommended for NHS use in draft guidance.

• Final draft guidance finds benefits of 2 Alzheimer’s treatments remain too small to justify the additional costs to the NHS

  The benefits from donanemab (also called Kisunla and made by Eli Lilly) and lecanemab (also called Leqembi and made by Eisai) - remain too small to justify the additional cost to the NHS, one of our independent committees has concluded following consultation.

• ‘Artificial pancreas’ transforming the lives of thousands of children and young people with type 1 diabetes

  The innovative hybrid closed loop (HCL) systems offer improved blood sugar control and can transform daily life for families managing this complex condition.